The Transformative Role of 3D Imaging in Preoperative Planning for Cardiac Device Placement

The landscape of cardiac surgery has undergone a dramatic shift over the past two decades, driven largely by advances in medical imaging. Nowhere is this more apparent than in the preoperative planning for cardiac device placement. From traditional pacemakers and implantable cardioverter‑defibrillators (ICDs) to complex left ventricular assist devices (LVADs) and transcatheter aortic valve replacements (TAVR), the need for precise anatomical understanding is paramount. Three‑dimensional imaging has emerged as an indispensable tool, providing surgeons and interventional cardiologists with high‑fidelity, patient‑specific anatomical models that significantly improve procedural safety and long‑term outcomes.

Unlike conventional two‑dimensional imaging, which can obscure critical spatial relationships, 3D imaging captures the heart and surrounding vasculature in volumetric detail. This allows clinicians to visualize not only the shape and size of target structures but also their relationship to nearby tissues, calcifications, and prior surgical hardware. As device complexity and patient comorbidity increase, the ability to simulate device placement before entering the operating room becomes a direct driver of better care. This article explores the key imaging modalities, their integration into clinical workflows, the evidence behind their benefits, practical challenges, and the near‑future innovations that promise to refine these techniques even further.

Key 3D Imaging Modalities and Their Applications

Multiple 3D imaging modalities are now routinely used in cardiac device planning. Each offers unique trade‑offs in spatial resolution, tissue contrast, temporal information, and radiation exposure. The choice of modality often depends on the specific device, the target anatomy, and the patient’s clinical profile.

Computed Tomography Angiography (CTA)

Cardiac CTA is the workhorse of preoperative 3D imaging for device placement. Modern dual‑source and wide‑detector CT scanners can acquire isotropic volumetric data of the entire heart in a single breath‑hold, with submillimeter resolution. CTA excels at visualizing coronary arteries, great vessels, and cardiac chambers, and it is particularly useful for sizing the aortic annulus and root before TAVR or for assessing left atrial appendage morphology prior to occlusion device deployment. The high spatial resolution allows accurate measurement of landing zones and detection of asymmetric calcifications that could impede device sealing.

One emerging application is the use of CTA to plan implantation of cardiac resynchronization therapy (CRT) devices. By identifying the coronary sinus anatomy, its branches, and the location of scar tissue via late enhancement imaging, physicians can select the optimal left ventricular lead target, improving response rates. Despite concerns about radiation and iodinated contrast, iterative reconstruction techniques and low‑kV protocols have substantially reduced dose, making routine pre‑procedural CTA feasible for most patients.

Cardiac Magnetic Resonance Imaging (MRI)

Cardiac MRI offers superior soft‑tissue contrast without ionizing radiation. For device planning, its greatest value lies in myocardial tissue characterization. Late gadolinium enhancement (LGE) can precisely delineate myocardial scar, which is critical for guiding ablation procedures and for avoiding lead placement in non‑viable tissue during CRT. Three‑dimensional whole‑heart sequences generate isotropic datasets that can be used for virtual device simulation, particularly for complex congenital heart disease patients who require custom‑built devices.

MRI is also increasingly integrated into the workflow for subcutaneous ICD (S‑ICD) planning. By visualizing the relationship between the heart, sternum, and subcutaneous tissues, MRI helps determine whether the device will achieve adequate sensing and defibrillation vector orientation. The major limitation remains the longer acquisition time, which can be problematic for patients with arrhythmias, and the absolute contraindication for patients with older, non‑MRI‑conditional devices.

3D Echocardiography (3DE)

Transthoracic and transesophageal 3D echocardiography provide real‑time, dynamic imaging of cardiac structures. This modality is especially valuable during transcatheter procedures, such as mitral valve repair with edge‑to‑edge clips or left atrial appendage closure. The real‑time component allows immediate feedback on device positioning and function, reducing the need for repeated fluoroscopy. 3D transesophageal echo (TEE) offers excellent visualization of the mitral valve apparatus, the interatrial septum, and the left atrial appendage orifice with high temporal resolution.

While 3DE has lower spatial resolution than CTA or MRI, its ability to capture moving structures in their natural state is irreplaceable. Modern echo systems can generate full‑volume pyramidal datasets that can be cropped and rotated, providing intuitive views for the interventional team. Integration with fluoroscopy via fusion imaging platforms further enhances procedural accuracy.

Hybrid and Fusion Techniques

No single modality covers every need. Fusion imaging—such as overlaying 3D CTA data onto live fluoroscopy—combines the high anatomical detail of pre‑procedural scans with real‑time guidance. Similarly, the co‑registration of 3D TEE with rotational angiography during structural heart procedures helps operators verify device alignment before release. These hybrid approaches are becoming standard in high‑volume centers and are supported by dedicated planning software that aligns multiple datasets in the same coordinate space.

The Preoperative Planning Workflow with 3D Imaging

Implementing 3D imaging effectively requires a structured workflow that bridges image acquisition, post‑processing, and clinical decision‑making. The following steps are typical in a modern cardiac device program.

Image Acquisition and Quality Assurance

The first step is to acquire a high‑quality volumetric dataset. For CTA, this involves ECG‑gating to minimize motion artifacts, careful contrast timing to ensure optimal opacification of the target chamber, and selection of reconstruction parameters (slice thickness 0.5–0.75 mm, overlap ~50%). For MRI, respiratory navigation or breath‑hold sequences are used. The imaging team must verify that the dataset covers the entire region of interest and is free from major artifacts before it is sent to the planning software.

Segmentation and 3D Reconstruction

Once the dataset is acquired, dedicated software segments the relevant structures. Semi‑automatic segmentation algorithms based on thresholding, region‑growing, or deep learning can rapidly extract the blood pool, myocardium, and calcifications. For challenging cases—such as post‑surgical patients with dense scar or prior coil implants—manual refinement by a trained technician may be required. The resulting 3D model can be exported as a surface mesh or a stereolithography (STL) file for 3D printing or as a series of multiplanar reformats for measurement.

Software Tools. Popular platforms include Mimics (Materialise), 3D Slicer (open source), OsiriX, and syngo.via (Siemens). Many of these offer specific modules for cardiac device planning, such as automatic detection of aortic annulus landmarks for TAVR sizing or left atrial appendage orifice measurement. Some platforms also support virtual stent or valve implantation, allowing the planner to test different device sizes and positions in a purely digital environment.

Virtual Simulation and Device Sizing

With the segmented 3D model loaded, the planning team can simulate device placement. This is particularly important for devices that require precise fixation, such as transcatheter heart valves or occluder devices. The virtual environment allows the user to measure critical dimensions (e.g., perimeter‑derived diameter, landing zone length, angle of approach) and to assess how a chosen device will interact with surrounding anatomy. Over‑sizing or under‑sizing can be detected before the real procedure, reducing the risk of paravalvular leak, embolization, or perforation.

For complex devices like LVADs, the surgeon can use the 3D model to plan the optimal inflow cannula position within the left ventricle, avoiding the papillary muscles and septal wall. In re‑do sternotomies, the model can reveal the exact location of coronary grafts relative to the sternum, allowing a safer entry point.

3D Printing for Hands‑On Planning

In selected cases, the digital 3D model is converted into a physical replica using 3D printing. Life‑sized, flexible models of the heart can be created from photopolymer or silicone materials that mimic tissue stiffness. Surgeons can handle the model, cut it, and practice device deployment. This tactile feedback can be invaluable for training and for rare or extremely challenging anatomies. Although additive manufacturing adds time and cost, its use in high‑risk procedures like complex congenital heart surgery or LVAD implantation has been shown to change the surgical approach in a significant percentage of cases.

Clinical Benefits and Evidence

The adoption of 3D‑guided planning has been supported by a growing body of clinical evidence showing improved outcomes across multiple device types.

Transcatheter Aortic Valve Replacement (TAVR)

Perhaps the strongest data come from TAVR. Pre‑procedural CTA is now a mandatory step in all commercially available TAVR valves. Studies have demonstrated that CTA‑based sizing reduces the incidence of paravalvular regurgitation and the need for post‑dilation compared to 2D echocardiography alone. A large meta‑analysis published in the Journal of the American College of Cardiology found that patients planned with CTA had significantly lower 30‑day mortality and stroke rates, likely due to more accurate selection of valve size and avoidance of aortic root injury. [External link: JACC study on CTA in TAVR planning]

Cardiac Resynchronization Therapy (CRT)

Use of 3D imaging in CRT has been associated with higher response rates. The MADIT‑CRT trial sub‑analysis showed that coronary venous anatomy derived from CTA was a strong predictor of LV lead positioning success. Additionally, patients who underwent MRI‑guided lead placement (targeting non‑scarred myocardium) had a significantly lower rate of heart failure hospitalization and death. [External link: MADIT-CRT trial results]

Left Atrial Appendage Closure (LAAC)

For LAAC devices, 3D TEE and CTA are routinely used to determine the shape and size of the appendage. A prospective registry demonstrated that when 3D‑guided sizing was used, the rate of peri‑device leak was reduced from 12% to 4%, and the need for device recapture was halved. The imaging‑derived measurement of the maximal landing zone diameter is now considered the gold standard.

Subcutaneous ICD Implantation

Pre‑procedural CT or MRI can predict the optimal sensing vector and help avoid inappropriate shocks. Studies have shown that 3D‑planned S‑ICD implants have lower rates of T‑wave oversensing and higher success rates of defibrillation testing.

Challenges and Limitations

Despite its clear advantages, the routine use of 3D imaging faces several hurdles that prevent universal adoption.

Cost and Resource Intensiveness

Cardiac CTA and MRI are expensive exams that require specialized equipment and expert personnel for both acquisition and interpretation. In many healthcare systems, reimbursement may not fully cover the added planning time, particularly for lower‑volume centers. The cost of software licences, workstation hardware, and 3D printing materials can further strain budgets.

Training and Workflow Integration

Effective use of 3D imaging demands a steep learning curve for surgeons, cardiologists, and radiologists. Many institutions lack dedicated planning teams, forcing clinicians to invest time outside of routine clinical duties. Integrating the 3D model into the operating room’s display system also requires technical coordination. Without seamless integration, the model remains a static report rather than an interactive guide.

Radiation and Contrast Exposure

CTA delivers ionizing radiation, and although newer scanners can achieve sub‑mSv doses for coronary imaging, complex cardiac protocols often exceed 5–10 mSv. In patients with renal impairment, iodinated contrast carries a risk of nephropathy. MRI avoids radiation but cannot be performed in patients with non‑conditional implants or severe claustrophobia, and gadolinium‑based contrast also has safety concerns in renal failure.

Motion Artifacts and Data Quality

The heart is a moving target. Even with retrospective ECG gating, arrhythmias can degrade CTA quality. For MRI, respiratory motion remains a challenge despite navigation. Poor image quality leads to inaccurate segmentation and potentially dangerous planning errors. Centers must have robust quality assurance processes to reject substandard datasets.

The next frontier in 3D imaging is the integration of artificial intelligence (AI) and extended reality (XR) technologies to streamline and enhance the planning process.

AI‑Powered Segmentation and Analysis

Deep learning models can now perform segmentation of cardiac structures in seconds, with accuracy comparable to expert manual tracing. These AI algorithms are being integrated directly into CT and MRI consoles, enabling on‑the‑fly measurement of aortic annulus dimensions, left atrial appendage volumes, and coronary sinus anatomy. Beyond segmentation, AI can predict device‑tissue interaction forces, suggest optimal implantation angles, and even flag anatomical variants that increase procedural risk. As these tools become validated and commercially available, the time and cost barrier of 3D planning will decrease significantly.

Augmented Reality (AR) in the Operating Room

AR overlays the patient’s body with the pre‑planned 3D model, directly visible to the surgeon through headsets such as the Microsoft HoloLens or as a projection on the fluoroscopy screen. Initial clinical studies in TAVR and LAAC have shown that AR guidance reduces fluoroscopy time and contrast use while improving deployment accuracy. The ability to see a “ghost” of the target device in real time gives the operator spatial confidence that was previously only available in virtual simulation. [External link: Clinical trial of AR in cardiac interventions]

Image‑Guided Robotics

Robotic catheter systems, such as the CorPath GRX, can accept 3D models for automated or semi‑automated device navigation. Future iterations will likely use AI to fuse live imaging with preoperative plans, allowing the robot to adjust its path in real time based on motion tracking. This promises a new level of precision, especially for challenging transseptal punctures or coronary sinus cannulation.

Case Example: 3D Imaging for Left Atrial Appendage Closure

To illustrate the integrated workflow, consider a patient with atrial fibrillation undergoing LAAC with a Watchman FLX device. The planning begins with a pre‑procedural CTA that provides a high‑resolution 3D data set. The imaging team segments the left atrial appendage, identifying the ostrum, landing zone, and lobes. Using planning software, the operator virtually places available device sizes (e.g., 27 mm, 31 mm, 35 mm) and chooses the one that provides the best compression and sealing with minimal protrusion into the pulmonary vein.

On the day of the procedure, 3D TEE is used to confirm the anatomical model and to guide the transseptal puncture. The pre‑planned model is fused with fluoroscopy, showing the ideal deployment angle and depth. During device release, real‑time 3D TEE checks for peri‑device leak and device stability. Post‑procedure, a follow‑up CTA at 45 days evaluates device endothelialization and confirms complete closure. This multi‑modality approach, driven by 3D imaging, has transformed LAAC from a risky experiment into a reliable, reproducible therapy with complication rates under 2% in experienced centers.

Conclusion: A Precision‑Driven Future

Three‑dimensional imaging is no longer a luxury in cardiac device placement—it is becoming the standard of care. By providing clinicians with a virtual blueprint of the patient’s unique anatomy, 3D imaging reduces procedural uncertainty, shortens operative times, and improves device performance and patient outcomes. Challenges of cost, training, and integration remain, but rapid advances in AI, AR, and robotics are poised to lower these barriers and expand access.

As the population ages and the demand for complex cardiac interventions grows, the ability to plan with millimeter precision will become even more critical. The evidence is clear: investing in 3D imaging capabilities pays dividends in safety, efficacy, and patient satisfaction. For cardiac centers seeking to advance their structural heart programs, a robust 3D imaging workflow is not just a nice‑to‑have—it is a clinical imperative.